|Articles|June 16, 2020
- PharmTech Sponsored eBooks-07-20-2020
- Volume Sponsored eBook
- Issue 10
Identifying and Quantifying Mutagenic Impurities in Pharmaceutical Products
Meeting detection challenges presented by nitrosamine impurities Determination of NDMA and nitrosamine impurities using triple-quadrupole LC/MS Determination of genotoxic impurities in ranitidine APIs and drug products
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
2
Integrating AI and Machine Learning in Drug Discovery and Development
3
EMA and FDA Collaborate on Framework for AI Use in Drug Development
4
Single-Use Systems Enable Commercial-Scale CGT Manufacturing
5